This inventor holds 11 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Cisen Pharmaceutical Co., Ltd., Syros Pharmaceuticals, Inc.. Active years: 2015-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shanghai, CN (2015 - 2019)
- Collegeville, PA (US) (2020)
- Acton, MA (US) (2019 - 2023)
Company Filing History:
9 out of 242 
1 out of 7 
1 out of 24 
Years Active: 2015-2023
Title: A Spotlight on Inventor Huiping Amy Guan
Introduction: Huiping Amy Guan is a distinguished inventor based in Shanghai, China, recognized for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, she has dedicated her career to the development of innovative compounds and therapeutic solutions that address critical health challenges.
Latest Patents: Among her most recent inventions are furin inhibitors, which are novel compounds designed to treat various fibrotic diseases such as pulmonary fibrosis, renal fibrosis, liver fibrosis, skin fibrosis, ocular fibrosis, cardiac fibrosis, and other related conditions. These compounds, outlined in her latest patent, also hold potential for treating other furin-mediated health issues, including hypertension, cancer, infectious diseases, genetic disorders like cystic fibrosis, and neurodegenerative disorders. Additionally, she has developed pyrrolotriazine compounds that involve methods for inhibiting TAM kinases, showcasing her commitment to advancing cancer treatment through innovative pharmaceutical compositions.
Career Highlights: Huiping Amy Guan has gained invaluable experience working at leading pharmaceutical companies. Notably, she has been associated with GlaxoSmithKline Intellectual Property Development Limited and Syros Pharmaceuticals, Inc., where her expertise in patent development has made substantial impacts on research and innovation.
Collaborations: Throughout her career, Huiping has collaborated with notable colleagues including Chengde Wu and Mui Cheung. These partnerships highlight the collaborative spirit essential for driving innovation within the pharmaceutical field.
Conclusion: Huiping Amy Guan represents a remarkable force in the realm of pharmaceutical innovation. Her continued focus on developing compounds for complex health challenges exemplifies the critical role that inventors play in advancing medical science and improving patient outcomes. As her work progresses, one can anticipate further breakthroughs stemming from her innovative spirit and expertise.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile